620 participants
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-19
- Start Date:
- 2024-08-12
- Completion:
- 2028-06-12
Conditions
- Biliary Tract Cancer
Interventions
- DRUG
No Results Yet